Bone Marrow TransplantationTransplantation, AutologousBone MarrowTransplantation, HomologousBone Marrow CellsBone Marrow PurgingWhole-Body IrradiationGraft vs Host DiseaseCombined Modality TherapyCyclophosphamideLymphoma, Non-HodgkinCarmustineHematopoietic Stem Cell TransplantationTransplantation ConditioningBusulfanLeukemiaBone and BonesMelphalanRemission InductionTissue DonorsAnemia, AplasticAntineoplastic Combined Chemotherapy ProtocolsGraft SurvivalLeukemia, Myeloid, AcuteHematopoietic Stem CellsRecurrenceEtoposideLiver TransplantationHodgkin DiseaseTransplantation ChimeraBone Marrow DiseasesCytarabineHematopoiesisTreatment OutcomeLeukemia, MyeloidPrecursor Cell Lymphoblastic Leukemia-LymphomaColony-Forming Units AssayHistocompatibility TestingActuarial AnalysisTransplantation, IsogeneicHistocompatibilitySurvival AnalysisTime FactorsKidney TransplantationAcute DiseaseVincristinePodophyllotoxinStem Cell TransplantationLymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRadiation ChimeraMice, Inbred C57BLHepatic Veno-Occlusive DiseaseDrug EvaluationDisease-Free SurvivalImmunosuppressionFollow-Up StudiesSurvival RateSalvage TherapyImmunosuppressive AgentsBone Marrow ExaminationLeukocyte CountMyelodysplastic SyndromesHematologic NeoplasmsGraft RejectionRetrospective StudiesGranulocyte Colony-Stimulating FactorT-LymphocytesThiotepaBone RemodelingTransplantation ImmunologyCyclosporineBone Marrow NeoplasmsGraft vs Host ReactionHematologic DiseasesMultiple MyelomaLymphocyte DepletionLeukocyte TransfusionHeart TransplantationPrognosisGranulocytesPrednisoneHLA AntigensPlatelet CountSevere Combined ImmunodeficiencyAntibodies, MonoclonalGranulocyte-Macrophage Colony-Stimulating FactorChimeraBlood Cell CountProspective StudiesLymphatic IrradiationMitoxantroneLung TransplantationGonadal DisordersNeuroblastomaCell SeparationLymphocyte TransfusionBone DensityCell DifferentiationDoxorubicin